• 05 Apr, 2026
CLOSE

Suggested:

Dr. Reddy’s Laboratories Receives GST Demand Orders Worth ₹2.20 Crore

Home Pharmaceuticals
Cipla Leadership Transition 2026: Umang Vohra Steps Down, New MD and Global CEO Appointed as Achin Gupta Takes the Helm
Medical News

Cipla Leadership Transition 2026: Umang Vohra Steps Down, New MD and Global CEO Appointed as Achin Gupta Takes the Helm

02 Apr, 2026 23 mins read 42 views

In the fast paced world of Indian pharmaceuticals, leadership changes can signal big shifts in strategy and growth. Today, Cipla Limited one of India’s most respected drugmakers officially entered a new chapter. Following a Board meeting on March 30, 2026 company announced that long time Managing Director and Global CEO Umang Vohra has stepped down effective April 1, 2026.

Medical News

Dr. Reddy’s Laboratories Receives GST Demand Orders Worth ₹2.20 Crore

20 Mar, 2026 14 mins read 81 views

Dr. Reddy’s Laboratories one of India’s leading pharmaceutical companies headquartered in Hyderabad, recently made headlines after disclosing GST demand orders totalling approximately ₹2.20 crore for the financial years FY20–22. Reported widely in March 2026, this development highlights the ongoing challenges companies face under India’s complex GST regime even those with strong compliance system.

Read More
Follow us
Categories
Lastest Post
L
Tags
T
DoctorsMBBSmedical collegeMedical Education Indiamedical negligencemedical negligence IndiahospitalmedicaleducationMedicalHealthcare
Your experience on this site will be improved by allowing cookies Cookie Policy